BriaCell Therapeutics Corp. (BCTX)
Largest Insider Buys in Sector
BCTX Stock Price History Chart
BCTX Stock Performance
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is …
Insider Activity of BriaCell Therapeutics Corp.
Over the last 12 months, insiders at BriaCell Therapeutics Corp. have bought $2M and sold $0 worth of BriaCell Therapeutics Corp. stock.
On average, over the past 5 years, insiders at BriaCell Therapeutics Corp. have bought $748,647 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lustig Marc () — $2M.
The last purchase of 902,935 shares for transaction amount of $2M was made by Lustig Marc () on 2024‑05‑14.
List of Insider Buy and Sell Transactions, BriaCell Therapeutics Corp.
| 2024-05-14 | 902,935 5.6265% | $2.21 | $2M | -61.18% | ||||
| 2022-12-28 | Chairman | 28,000 0.3608% | $4.58 | $128,240 | +40.66% | |||
| 2022-12-20 | director | 22,000 0.3311% | $5.35 | $117,700 | +21.44% |
Insider Historical Profitability
| Lustig Marc | 2542935 5.7527% | $0.54 | 1 | 0 | ||
| Bondarenko Jamieson | Chairman | 169856 0.3843% | $0.54 | 2 | 0 | +31.05% |